No Effective Treatment for Hantavirus Yet, EMA Announces

Currently, there are no approved specialized medications or vaccines for hantavirus. The European Medicines Agency (EMA) has stated that treatment for individuals infected with hantavirus is limited to supportive therapy only. In the absence of specific antiviral agents, it is crucial to transfer patients to intensive care units in a timely manner, where proper medical assistance can be provided.

The regulatory body has indicated its readiness to support the development of vaccines and new medications against the virus. The agency is continuously monitoring the situation and encourages scientific research that could aid in the identification of effective disease prevention methods.

At the same time, the EU institution has refuted circulating claims that hantavirus is linked to COVID-19 vaccines. Such allegations have been characterized as disinformation lacking scientific basis. Experts urge trust in only official and verified data.